Russell Investments Group, Ltd. Exagen Inc. Transaction History

Russell Investments Group, Ltd.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	BUY	$7.12 - $11.06 $24,485 - $38,035	3,439 New	3,439 $27,000
Q4 2021 Jan 21, 2022	SELL	$8.97 - $14.08 $235,803 - $370,135	-26,288 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$10.25 - $15.21 $25,666 - $38,085	-2,504 Reduced 8.7%	26,288 $357,000
Q2 2021 Aug 04, 2021	SELL	$12.4 - $17.92 $739,374 - $1.07 Million	-59,627 Reduced 67.44%	28,792 $430,000
Q1 2021 May 10, 2021	BUY	$13.9 - $22.0 $1.2 Million - $1.9 Million	86,410 Added 4301.14%	88,419 $1.55 Million
Q4 2020 Feb 08, 2021	SELL	$11.19 - $16.05 $282,983 - $405,888	-25,289 Reduced 92.64%	2,009 $25,000
Q3 2020 Nov 09, 2020	SELL	$10.56 - $16.69 $541,749 - $856,230	-51,302 Reduced 65.27%	27,298 $295,000
Q2 2020 Aug 05, 2020	SELL	$11.0 - $16.7 $280,379 - $425,666	-25,489 Reduced 24.49%	78,600 $973,000
Q1 2020 May 06, 2020	SELL	$12.7 - $25.95 $133,680 - $273,149	-10,526 Reduced 9.18%	104,089 $1.65 Million
Q4 2019 Jan 29, 2020	BUY	$12.61 - $28.48 $656,463 - $1.48 Million	52,059 Added 83.22%	114,615 $2.91 Million
Q3 2019 Nov 01, 2019	BUY	$14.5 - $17.5 $907,062 - $1.09 Million	62,556 New	62,556 $967,000

6.41M

4.5K

400

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $89.8M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.